143 related articles for article (PubMed ID: 38069020)
1. HLA-E and Its Soluble Form as Indicators of a Sex-Specific Immune Response in Patients with Oral Squamous Cell Carcinoma.
Radermacher A; Fehrenz M; Bellin T; Claßen C; Möller L; Struckmeier AK; Wagner M; Wartenberg P; Moratin J; Freudlsperger C; Freier K; Horn D
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069020
[TBL] [Abstract][Full Text] [Related]
2. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.
Lin A; Zhang X; Zhou WJ; Ruan YY; Xu DP; Wang Q; Yan WH
Int J Cancer; 2011 Sep; 129(6):1382-90. PubMed ID: 21128238
[TBL] [Abstract][Full Text] [Related]
4. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
Ugurel S; Rebmann V; Ferrone S; Tilgen W; Grosse-Wilde H; Reinhold U
Cancer; 2001 Jul; 92(2):369-76. PubMed ID: 11466692
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive mediators of oral squamous cell carcinoma in tumour samples and saliva.
Gonçalves AS; Arantes DA; Bernardes VF; Jaeger F; Silva JM; Silva TA; Aguiar MC; Batista AC
Hum Immunol; 2015 Jan; 76(1):52-8. PubMed ID: 25500427
[TBL] [Abstract][Full Text] [Related]
7. HLA-G as a new tumor biomarker: detection of soluble isoforms of HLA-G in the serum and saliva of patients with colorectal cancer.
Lázaro-Sánchez AD; Salces-Ortiz P; Velásquez LI; Orozco-Beltrán D; Díaz-Fernández N; Juárez-Marroquí A
Clin Transl Oncol; 2020 Jul; 22(7):1166-1171. PubMed ID: 31748960
[TBL] [Abstract][Full Text] [Related]
8. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
9. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
[TBL] [Abstract][Full Text] [Related]
10. Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients.
Yan WH; Liu D; Lu HY; Li YY; Zhang X; Lin A
J Cell Mol Med; 2015 Apr; 19(4):778-85. PubMed ID: 25689063
[TBL] [Abstract][Full Text] [Related]
11. HLA-G Expression is Associated with an Unfavorable Prognosis of Oral Squamous Cell Carcinoma.
Imani R; Seyedmajidi M; Ghasemi N; Moslemi D; Shafaee S; Bijani A
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2527-2533. PubMed ID: 30256047
[TBL] [Abstract][Full Text] [Related]
12. Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
Kirana C; Ruszkiewicz A; Stubbs RS; Hardingham JE; Hewett PJ; Maddern GJ; Hauben E
Int J Cancer; 2017 Jun; 140(11):2577-2586. PubMed ID: 28233298
[TBL] [Abstract][Full Text] [Related]
13. Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients.
Morandi F; Pozzi S; Carlini B; Amoroso L; Pistoia V; Corrias MV
J Immunol Res; 2016; 2016():7465741. PubMed ID: 27610393
[TBL] [Abstract][Full Text] [Related]
14. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
15. [Application value of whole exon sequencing and immune related indicators in the precision treatment of oral squamous cell carcinoma].
Xie S; Cai ZG; Shan XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):697-701. PubMed ID: 37534654
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of immunomodulatory mediators in oral precancerous lesions.
Gonçalves AS; Mosconi C; Jaeger F; Wastowski IJ; Aguiar MCF; Silva TA; Ribeiro-Rotta RF; Costa NL; Batista AC
Hum Immunol; 2017 Nov; 78(11-12):752-757. PubMed ID: 28941745
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.
König L; Kasimir-Bauer S; Hoffmann O; Bittner AK; Wagner B; Manvailer LF; Schramm S; Bankfalvi A; Giebel B; Kimmig R; Horn PA; Rebmann V
Hum Immunol; 2016 Sep; 77(9):791-9. PubMed ID: 26796737
[TBL] [Abstract][Full Text] [Related]
18. An inverse association of Helicobacter pylori infection with oral squamous cell carcinoma.
Meng X; Wang Q; He C; Chen M; Liu J; Liu W; Yuan Y
J Oral Pathol Med; 2016 Jan; 45(1):17-22. PubMed ID: 25899621
[TBL] [Abstract][Full Text] [Related]
19. Correlation between human leukocyte antigen-G expression and clinical parameters in oral squamous cell carcinoma.
Shen X; Wang P; Dai P; Jin B; Tong Y; Lin H; Shi G
Indian J Cancer; 2018; 55(4):340-343. PubMed ID: 30829267
[TBL] [Abstract][Full Text] [Related]
20. HLA-E polymorphism and soluble HLA-E plasma levels in chronic hepatitis B patients.
Zidi I; Laaribi AB; Bortolotti D; Belhadj M; Mehri A; Yahia HB; Babay W; Chaouch H; Zidi N; Letaief A; Yacoub S; Boukadida J; Di Luca D; Hannachi N; Rizzo R
HLA; 2016 Mar; 87(3):153-9. PubMed ID: 26956431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]